WORX appears to have undergone a fundamental business transformation, relocating from Tampa to Massachusetts while completely removing all healthcare IT business descriptions from its filing.
The complete elimination of healthcare technology business descriptions, combined with a relocation and downsizing to just 9 employees, suggests either a major pivot away from the healthcare IT sector or potential winding down of core operations. This represents a fundamental change in the company's business model and strategic direction that investors need to understand.
The company shows mixed operational results with improved gross profit of $920K and reduced operating losses, while interest expense dropped substantially to $24K from $259K. However, cash position weakened significantly to $91K from $249K, and operating cash flow deteriorated meaningfully. The balance sheet strengthened through a large reduction in total liabilities to $744K and increased stockholders equity to $7.2M, though inventory declined sharply to $157K, possibly reflecting business model changes or liquidation activities.
Interest expense declined — debt repayment or refinancing at lower rates improving earnings quality.
Inventory drawn down 84.3% — strong sell-through or deliberate destocking; watch for supply constraints.
Cash declined 63.3% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.
Liabilities reduced 59.9% — deleveraging improves balance sheet strength and financial flexibility.
Current liabilities reduced — improved short-term financial position and working capital health.
Equity base grew 59.3% — retained earnings accumulation or equity issuance strengthening the balance sheet.
Operating cash flow fell 42.4% — earnings quality concerns; investigate working capital changes and non-cash items.
Asset base grew 24.4% — expansion through organic growth, acquisitions, or capital deployment.
Operating income improving — cost discipline or growing revenue base absorbing fixed costs.
Gross profit expanding — improving pricing power or product mix shift toward higher-margin offerings.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →